Product
Gemcitabine&Cisplatin
1 clinical trial
1 indication
Indication
Biliary Tract NeoplasmsClinical trial
A Randomized, Open-Label, Multicenter Phase 2 Study of Envafolimab in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin as the First-line Treatment in Patients With Locally Advanced or Metastatic Biliary Tract CancersStatus: Not yet recruiting, Estimated PCD: 2026-06-01